Presentation: Additional Anatomic Endpoints Support Sustained Outcomes With Faricimab Every 16 Weeks in the STAIRWAY Phase 2 Trial for neovascular AMD

David A Eichenbaum MD
Retina Vitreous Associates of Florida
SAINT PETERSBURG (727) 323-0077
CLEARWATER (727) 445-9110
TAMPA (813) 879-5795
https://retinavitreous.com